Viewing StudyNCT00028067



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00028067
Status: TERMINATED
Last Update Posted: 2011-05-04
First Post: 2001-12-10

Brief Title: A Comparison of Atazanavir and Nelfinavir Each in Combination With 2 NRTIs in Patients Who Have Failed Treatments Without a Protease Inhibitor
Sponsor:
Organization: Bristol-Myers Squibb

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 500
Enrollment Type: None
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: